Lonza Group AG
Lonza Group AG (LZAGF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · LZAGF · as of Jun 8, 2026
Key Statistics
Explore Lonza Group AG Data
lzagf stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 1 · Buy rate: 100.0%
Competitors & Peers
lzagf competitorsLZAGF
CHALF
DSKYF
DSNKY
HLNCF
HOCPFStock Performance
Full HistoryAbout Lonza Group AG
Lonza Group AG together with its subsidiaries, supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe, North and Central America, Latin America, Asia, Aus…
what is lonza group ag · lzagf stock overview · lonza group ag company profile · who is lonza group ag ceo · lzagf OTC · lonza group ag headquarters · lonza group ag business segments
About Stock Overview & Key Data
Lonza Group AG (LZAGF) is a Healthcare company in the Medical - Diagnostics & Research industry, listed on OTC since Feb 13, 2009. As of the latest trading session, LZAGF stock price is $597.72, with a market capitalization of $41.7B. The stock has returned -14.73% over the past 12 months and -12.16% year-to-date.
According to 1 Wall Street analysts, the consensus rating for Lonza Group AG stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, Lonza Group AG reported revenue of $6.5B and net income of $949.0M. For detailed data — including Lonza Group AG revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Lonza Group AG (LZAGF) stock price is $597.72. The stock is traded on OTC under the ticker symbol LZAGF. The 52-week range is $565.14 – $755.96.